StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
1031
This month
13
This week
6
This year
106
Publishing Date
2024 - 01 - 17
5
2023 - 12 - 12
5
2023 - 12 - 11
4
2023 - 12 - 08
5
2023 - 11 - 01
4
2023 - 10 - 30
4
2023 - 10 - 04
4
2023 - 10 - 03
4
2023 - 10 - 02
4
2023 - 09 - 29
4
2023 - 08 - 28
4
2023 - 08 - 25
7
2023 - 08 - 09
5
2023 - 06 - 12
5
2023 - 06 - 08
5
2023 - 04 - 26
5
2023 - 04 - 25
4
2023 - 04 - 13
6
2023 - 04 - 12
12
2023 - 03 - 16
4
2023 - 02 - 27
4
2023 - 02 - 24
4
2023 - 02 - 22
4
2023 - 02 - 20
5
2023 - 02 - 17
7
2023 - 02 - 16
5
2023 - 02 - 13
6
2023 - 02 - 08
4
2023 - 01 - 18
4
2023 - 01 - 16
4
2022 - 09 - 28
4
2022 - 09 - 19
6
2022 - 09 - 02
4
2022 - 08 - 03
4
2022 - 07 - 25
4
2022 - 06 - 27
4
2022 - 06 - 24
4
2022 - 06 - 17
6
2022 - 05 - 27
5
2022 - 05 - 25
4
2022 - 05 - 05
4
2022 - 04 - 26
4
2022 - 03 - 25
6
2022 - 03 - 22
4
2022 - 03 - 17
4
2022 - 03 - 04
4
2022 - 03 - 01
4
2021 - 12 - 22
6
2021 - 12 - 20
4
2021 - 12 - 14
3
2021 - 11 - 12
3
2021 - 11 - 04
3
2021 - 11 - 02
3
2021 - 10 - 28
4
2021 - 10 - 22
3
2021 - 10 - 21
3
2021 - 10 - 20
4
2021 - 10 - 13
3
2021 - 10 - 08
3
2021 - 10 - 01
3
Sector
Commercial services
8
Communications
8
Consumer durables
5
Consumer non-durables
15
Consumer services
2
Distribution services
4
Electronic technology
18
Finance
5
Health care and social assistance
1
Health services
16
Health technology
1031
Industrial services
1
Information
4
Manufacturing
135
Mining, quarrying, and oil and gas extraction
2
N/a
68
Non-energy minerals
1
Process industries
13
Producer manufacturing
16
Professional, scientific, and technical services
18
Retail trade
3
Technology services
16
Tags
Agreement
8
Alzheimer's
10
America
67
Antibody
8
Application
8
Approval
13
Biosimilar
32
Breast
13
Business
9
Cancer
91
Cell
9
Chmp
10
Diabetes
15
Diagnostics
17
Disease
61
Drug
85
Earnings
18
Europe
15
Expansion
10
Expected
35
Eye
15
Fda
22
Financial
24
Global
228
Growing
43
Growth
235
Health
19
Immunotherapy
11
Infection
9
Kisqali
11
Leukemia
10
Liver
11
Market
592
N/a
945
Novartis
132
People
13
Pharma
13
Pharmaceuticals
17
Pipeline
12
Positive
15
Potential
10
Reach
34
Report
194
Research
118
Respiratory
11
Results
38
Risk
10
Sales
9
Sclerosis
13
Set
15
Study
15
T-cell
11
Technology
12
Therapeutics
109
Therapy
64
Treatment
113
Trial
16
Update
10
Vaccine
10
Year
12
Entities
3m company
8
Abbott laboratories
105
Abbvie inc.
218
Abeona therapeutics inc.
7
Adaptimmune therapeutics plc
12
Alcon inc.
14
Alkermes plc
7
Amgen inc.
168
Astellas pharma inc
70
Astrazeneca plc
171
Autolus therapeutics plc
7
Bausch health companies inc.
61
Baxter international inc.
45
Becton, dickinson and company
17
Beigene, ltd.
7
Biogen inc.
47
Biomarin pharmaceutical inc.
6
Biontech se
9
Boston scientific corporation
13
Brainstorm cell therapeutics inc.
8
Bristol-myers squibb company
82
Chinook therapeutics, inc.
7
Csl ltd
9
Danaher corporation
10
Eli lilly and company
121
Endo international plc
20
General electric company
8
Genmab a/s
12
Gilead sciences, inc.
25
Glaxosmithkline plc
264
Grifols sa
10
Incyte corporation
15
Ionis pharmaceuticals, inc.
7
Jazz pharmaceuticals plc
13
Johnson & johnson
189
Koninklijke philips n.v.
17
Mallinckrodt plc
17
Medtronic plc
29
Morphosys ag
12
Novartis ag
1031
Novo nordisk a/s
27
Orange
8
Orchard therapeutics plc
8
Perrigo company
7
Pfizer, inc.
68
Precision biosciences, inc.
8
Reckitt benckiser group plc
9
Regeneron pharmaceuticals, inc.
12
Regenxbio inc.
11
Sanofi
284
Smith & nephew plc
7
Stryker corporation
10
Takeda pharmaceutical company limited
51
Terumo corp
9
Teva pharmaceutical industries limited
9
Teva pharmaceutical industries ltd
206
Thermo fisher scientific inc
48
Ucb s.a.
8
Viatris inc.
115
Xencor, inc.
9
Symbols
AAPL
1198
ABB
1427
ABBV
1024
ABLZF
1166
ABT
1787
ACN
600
AMGN
742
ARVL
4294
AVGO
593
AZN
665
BDX
796
BMY
662
BNPQF
1764
BNPQY
1764
CSCO
897
DHR
785
ERIC
1612
F
641
FNCTF
7191
FRBA
598
GE
917
GLAXF
658
GOOG
1281
GOOGL
1280
GSK
884
HON
1787
HUBS
1400
IBM
655
INTC
955
IT
594
JNJ
4583
LLY
1709
LTUM
971
LYV
717
MDT
1285
MMM
938
MS
4286
MSFT
1201
MT
589
NOK
901
NOKBF
975
NVO
632
NVS
1241
NVSEF
1031
ORCL
1158
PCRFF
650
PCRFY
650
PFE
692
PHG
962
PPRUF
1128
PPRUY
1129
SAP
1477
SAPGF
1231
SNOW
796
SNY
4539
SNYNF
3597
TEVJF
631
TMO
1623
VZ
1213
XYF
676
Exchanges
Amex
6
Nasdaq
1031
Nyse
1031
Crawled Date
2024 - 01 - 17
5
2023 - 12 - 12
5
2023 - 12 - 11
4
2023 - 12 - 08
6
2023 - 11 - 01
4
2023 - 10 - 30
4
2023 - 10 - 04
4
2023 - 10 - 03
4
2023 - 10 - 02
4
2023 - 09 - 29
4
2023 - 08 - 28
4
2023 - 08 - 25
7
2023 - 08 - 09
4
2023 - 06 - 12
5
2023 - 06 - 08
5
2023 - 04 - 28
4
2023 - 04 - 26
5
2023 - 04 - 25
4
2023 - 04 - 13
6
2023 - 04 - 12
12
2023 - 03 - 16
4
2023 - 02 - 27
4
2023 - 02 - 24
4
2023 - 02 - 22
4
2023 - 02 - 20
4
2023 - 02 - 17
7
2023 - 02 - 16
5
2023 - 02 - 14
4
2023 - 02 - 13
4
2023 - 01 - 18
4
2023 - 01 - 16
4
2022 - 12 - 15
4
2022 - 09 - 28
4
2022 - 09 - 19
6
2022 - 09 - 13
4
2022 - 09 - 02
4
2022 - 08 - 03
4
2022 - 07 - 25
4
2022 - 06 - 27
4
2022 - 06 - 24
4
2022 - 06 - 17
6
2022 - 05 - 27
5
2022 - 05 - 25
4
2022 - 05 - 05
4
2022 - 04 - 26
4
2022 - 03 - 25
6
2022 - 03 - 22
4
2022 - 03 - 17
4
2022 - 03 - 14
4
2022 - 03 - 04
4
2021 - 12 - 22
5
2021 - 12 - 20
4
2021 - 11 - 04
3
2021 - 11 - 02
3
2021 - 10 - 28
4
2021 - 10 - 21
3
2021 - 10 - 20
4
2021 - 10 - 13
3
2021 - 10 - 08
3
2021 - 10 - 01
3
Crawled Time
00:00
42
00:20
9
01:00
44
02:00
25
03:00
33
04:00
19
04:20
8
05:00
23
06:00
58
07:00
34
08:00
27
08:20
4
09:00
40
10:00
30
11:00
43
11:01
1
12:00
68
12:20
14
12:30
8
13:00
26
13:15
2
13:20
7
13:30
4
14:00
33
14:15
1
14:20
10
14:30
7
14:49
1
15:00
40
15:15
1
15:20
16
15:30
14
16:00
49
16:20
3
17:00
49
18:00
48
19:00
43
20:00
35
20:20
3
21:00
26
22:00
43
23:00
40
Source
investors.biomarin.com
1
ir.voyagertherapeutics.com
2
www.biospace.com
86
www.globenewswire.com
173
www.perion.com
1
www.precisionbiosciences.com
3
www.prnewswire.com
764
www.voyagertherapeutics.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
Nvsef
save search
Global Prescription Drugs Market Analysis Report 2022: Increasing Number of Chronic Diseases Worldwide will Continue to Fuel Growth - Forecast to 2027
Published:
2023-01-19
(Crawled : 17:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
14.14%
|
O:
0.69%
H:
0.0%
C:
-1.52%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-4.71%
|
O:
1.26%
H:
1.19%
C:
1.19%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-18.53%
|
O:
-0.31%
H:
1.15%
C:
0.68%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-10.9%
|
O:
0.13%
H:
0.65%
C:
0.51%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
1.0%
|
O:
-0.1%
H:
0.31%
C:
0.17%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-14.61%
|
O:
-0.43%
H:
1.33%
C:
0.3%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
12.53%
|
O:
0.17%
H:
1.36%
C:
1.02%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
113.28%
|
O:
0.1%
H:
0.97%
C:
-0.37%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-33.05%
|
O:
0.29%
H:
2.1%
C:
1.94%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
10.7%
|
O:
-0.17%
H:
1.07%
C:
-0.16%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-8.54%
|
O:
-0.92%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-20.11%
|
O:
0.51%
H:
0.49%
C:
-0.65%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
0.21%
|
O:
-0.9%
H:
0.58%
C:
0.01%
global
report
growth
market
Pharmascience Canada launched (PR)pms-DEFERASIROX (TYPE J), a generic drug indicated in the management of chronic iron
Published:
2023-01-18
(Crawled : 19:00)
- biospace.com/
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
22.87%
|
O:
0.05%
H:
0.0%
C:
0.0%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
0.76%
|
O:
0.93%
H:
0.01%
C:
-1.16%
management
drug
canada
Dermatology Drugs Market to Experience Substantial Growth of USD 37.33 Million by 2029, Size, Share, Growth Rate, Market Demand, Opportunities and Competitive Landscape: Report by Data Bridge Market Research
Published:
2023-01-18
(Crawled : 19:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-4.71%
|
O:
1.26%
H:
1.19%
C:
1.19%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
1.0%
|
O:
-0.1%
H:
0.31%
C:
0.17%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-14.61%
|
O:
-0.43%
H:
1.33%
C:
0.3%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-33.05%
|
O:
0.29%
H:
2.1%
C:
1.94%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-8.54%
|
O:
-0.92%
H:
0.0%
C:
0.0%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
0.21%
|
O:
-0.9%
H:
0.58%
C:
0.01%
research
report
growth
market
Worldwide Monoclonal Antibodies Industry to 2033 - Rising mAb Therapy Applications for Targeted Therapies Drives Growth
Published:
2023-01-18
(Crawled : 18:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
13.48%
|
O:
1.12%
H:
0.0%
C:
-1.68%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-7.09%
|
O:
-2.5%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
-5.79%
|
O:
-1.16%
H:
1.62%
C:
-0.54%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
22.87%
|
O:
0.05%
H:
0.0%
C:
0.0%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
-6.08%
|
O:
-0.17%
H:
0.25%
C:
-2.96%
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
|
-9.33%
|
O:
0.56%
H:
0.97%
C:
-1.87%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-10.4%
|
O:
0.57%
H:
0.84%
C:
-0.01%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
0.76%
|
O:
0.93%
H:
0.01%
C:
-1.16%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-15.9%
|
O:
-0.41%
H:
0.2%
C:
-1.1%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
11.36%
|
O:
-0.03%
H:
0.17%
C:
-1.01%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
109.86%
|
O:
-0.4%
H:
0.75%
C:
-1.21%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-6.16%
|
O:
-0.16%
H:
0.33%
C:
-1.5%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-8.67%
|
O:
-0.14%
H:
0.0%
C:
0.0%
BIIB
|
$194.39
2.03%
1.99%
1.6M
|
Health Technology
|
-32.61%
|
O:
0.34%
H:
0.46%
C:
-2.45%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
-3.5%
|
O:
1.36%
H:
0.33%
C:
-1.13%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-1.66%
|
O:
0.0%
H:
0.41%
C:
-1.87%
therapy
growth
LAMEA Attention Deficit Hyperactivity Disorder Market 2022: Sector to Grow by 7.3% Annually Through 2028
Published:
2023-01-18
(Crawled : 12:00)
- prnewswire.com
MNK
|
$0.3402
-0.06%
540K
|
n/a
|
-94.91%
|
O:
-0.13%
H:
3.25%
C:
-3.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
22.87%
|
O:
0.05%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-18.58%
|
O:
0.62%
H:
0.12%
C:
-0.68%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-44.84%
|
O:
-1.16%
H:
0.67%
C:
-1.2%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
0.76%
|
O:
0.93%
H:
0.01%
C:
-1.16%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-15.9%
|
O:
-0.41%
H:
0.2%
C:
-1.1%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
109.86%
|
O:
-0.4%
H:
0.75%
C:
-1.21%
SUPN
|
$29.43
1.94%
1.9%
360K
|
Health Technology
|
-27.97%
|
O:
0.07%
H:
2.69%
C:
0.32%
market
Multiple Sclerosis Patients in US Left Without Essential Patient Support Program Will Now Receive Equivalent Backing From Cycle Pharmaceuticals Following FDA’s Approval of TASCENSO ODT® (fingolimod)
Published:
2023-01-17
(Crawled : 19:00)
- biospace.com/
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
2.22%
|
O:
2.34%
H:
0.04%
C:
-0.87%
odt
pharmaceuticals
program
approval
sclerosis
Dry Eye Products Global Market Report 2022: Sector to Reach $9.68 Billion by 2028 at a 5.1% CAGR
Published:
2023-01-16
(Crawled : 20:00)
- prnewswire.com
PBH
|
$69.67
1.93%
0.0%
450K
|
Health Technology
|
2.12%
|
O:
-0.27%
H:
1.52%
C:
-0.9%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
2.22%
|
O:
2.34%
H:
0.04%
C:
-0.87%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
7.53%
|
O:
0.13%
H:
0.85%
C:
-0.63%
global
report
eye
market
The Worldwide Dry Eye Syndrome Treatment Industry is Expected to Reach $6.5 Billion by 2028
Published:
2023-01-16
(Crawled : 17:00)
- prnewswire.com
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
OYST
|
$11.17
0.18%
-0.27%
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
treatment
eye
expected
Global Active Pharmaceutical Ingredients (APIs) Market Report, 2022 & 2023-2027: Biotech APIs Used in Biologics are Increasingly Becoming the Top-Selling Drugs in the Market
Published:
2023-01-16
(Crawled : 15:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
Email alert
Add to watchlist
global
active
biotech
market
Diabetic Macular Edema Treatment Global Market Report 2022: Prevalence of Diabetes Worldwide Bolsters Sector
Published:
2023-01-16
(Crawled : 12:00)
- prnewswire.com
IEX
|
$227.04
0.42%
0.0%
240K
|
Producer Manufacturing
|
Email alert
Add to watchlist
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
IRIX
|
$2.95
-2.32%
-2.37%
50K
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
treatment
global
report
macular
diabetes
market
diabetic
The Worldwide Lysosomal Disease Treatment Industry is Expected to Reach $11 Billion by 2028
Published:
2023-01-13
(Crawled : 13:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-6.69%
|
O:
-0.13%
H:
0.76%
C:
0.76%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
-2.42%
|
O:
2.77%
H:
0.63%
C:
0.63%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-16.45%
|
O:
0.13%
H:
2.35%
C:
2.16%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-46.72%
|
O:
-0.44%
H:
1.39%
C:
0.74%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
2.78%
|
O:
0.15%
H:
0.65%
C:
0.4%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-16.7%
|
O:
-0.47%
H:
0.47%
C:
0.14%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
109.06%
|
O:
0.13%
H:
1.04%
C:
0.57%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.9%
|
O:
1.89%
H:
0.0%
C:
0.0%
BMRN
|
$88.68
-1.54%
-1.57%
1.8M
|
Health Technology
|
-19.79%
|
O:
-1.16%
H:
2.27%
C:
0.42%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
-2.59%
|
O:
1.27%
H:
0.78%
C:
0.15%
treatment
disease
expected
Analgesics Global Market Report 2022: Increasing Number of Strategic Collaborations and Advancements in Medical Drug Development Present Opportunities
Published:
2023-01-12
(Crawled : 21:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
15.76%
|
O:
0.09%
H:
0.0%
C:
-0.29%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-6.69%
|
O:
-0.13%
H:
0.76%
C:
0.76%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
2.78%
|
O:
0.15%
H:
0.65%
C:
0.4%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
12.66%
|
O:
0.14%
H:
0.77%
C:
0.51%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-4.45%
|
O:
-0.08%
H:
2.35%
C:
2.01%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.9%
|
O:
1.89%
H:
0.0%
C:
0.0%
drug
global
report
medical
market
Generic drugs market size to increase by USD 176.25 billion; North America to contribute 37% of market growth - Technavio
Published:
2023-01-11
(Crawled : 00:00)
- prnewswire.com
ENDPQ
|
$0.0006
-50.0%
3.4K
|
n/a
|
-95.63%
|
O:
-3.17%
H:
7.0%
C:
1.69%
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
19.06%
|
O:
5.87%
H:
0.0%
C:
0.0%
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
15.17%
|
O:
-0.51%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-4.82%
|
O:
0.37%
H:
1.64%
C:
1.64%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
24.23%
|
O:
0.37%
H:
0.0%
C:
-0.49%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
-5.52%
|
O:
-0.08%
H:
0.6%
C:
-0.85%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
2.88%
|
O:
-0.46%
H:
0.91%
C:
0.57%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
14.22%
|
O:
0.2%
H:
1.55%
C:
1.18%
BAX
|
$39.47
-0.45%
0.0%
2.8M
|
Health Technology
|
-12.63%
|
O:
-0.11%
H:
0.55%
C:
-0.66%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-5.97%
|
O:
-1.03%
H:
0.35%
C:
-0.56%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-6.26%
|
O:
-0.38%
H:
0.0%
C:
0.0%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-2.92%
|
O:
-0.36%
H:
0.27%
C:
-0.37%
america
growth
market
Acute Migraine Treatment Market Value to Exceed US$ 7.9 Billion by 2031, Reveals Transparency Market Research
Published:
2023-01-11
(Crawled : 12:00)
- prnewswire.com
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-46.62%
|
O:
0.17%
H:
0.08%
C:
-0.52%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
2.92%
|
O:
0.52%
H:
0.07%
C:
-0.48%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-17.25%
|
O:
0.23%
H:
0.09%
C:
-0.39%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
112.83%
|
O:
0.45%
H:
2.09%
C:
1.71%
treatment
research
migraine
market
Anti-inflammatory therapeutics market size to increase by USD 39.32 billion; North America to contribute 45% of market growth - Technavio
Published:
2023-01-09
(Crawled : 00:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
16.16%
|
O:
-0.52%
H:
1.79%
C:
1.73%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
3.48%
|
O:
0.31%
H:
0.66%
C:
0.23%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
14.68%
|
O:
0.58%
H:
0.39%
C:
0.03%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
2.17%
|
O:
0.35%
H:
0.12%
C:
-1.6%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-6.4%
|
O:
-0.49%
H:
0.0%
C:
0.0%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-1.92%
|
O:
0.68%
H:
0.98%
C:
0.71%
america
therapeutics
growth
market
CAR-T Cell Therapy Market Size to Reach USD 9.62 Million in 2030| Emergen Research
Published:
2023-01-09
(Crawled : 16:00)
- prnewswire.com
ALPMF
|
$9.17
43.47%
16K
|
Health Technology
|
-32.44%
|
O:
3.03%
H:
0.0%
C:
0.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
24.84%
|
O:
3.12%
H:
0.0%
C:
-2.55%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-35.94%
|
O:
0.58%
H:
0.44%
C:
-0.31%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
0.86%
|
O:
0.76%
H:
0.26%
C:
-3.27%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
106.86%
|
O:
0.29%
H:
0.27%
C:
-3.89%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-33.84%
|
O:
0.16%
H:
0.05%
C:
-2.89%
BNTX
|
$86.82
0.75%
0.75%
1.6M
|
Health Technology
|
-42.59%
|
O:
1.42%
H:
0.64%
C:
-2.27%
research
car-t
therapy
market
Global Spinal Muscular Atrophy Treatment Market Report 2022: Sector to Reach $11.4 Billion by 2028 at a 17.8% CAGR
Published:
2023-01-09
(Crawled : 15:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
24.84%
|
O:
3.12%
H:
0.0%
C:
-2.55%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-50.08%
|
O:
-1.71%
H:
0.42%
C:
-3.32%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
0.86%
|
O:
0.76%
H:
0.26%
C:
-3.27%
BHVN
1 d
|
$38.99
-7.52%
0.0%
3.4M
|
Health Technology
|
192.17%
|
O:
0.35%
H:
9.67%
C:
3.25%
SRRK
4
|
$13.85
-0.72%
-0.72%
710K
|
Health Technology
|
46.37%
|
O:
1.5%
H:
2.42%
C:
-0.11%
PTCT
|
News
S
|
$25.32
2.55%
2.49%
3.9M
|
Health Technology
|
-36.03%
|
O:
0.1%
H:
10.44%
C:
5.66%
IONS
|
$40.64
-0.42%
-0.42%
850K
|
Health Technology
|
0.72%
|
O:
-0.17%
H:
0.84%
C:
-7.91%
treatment
global
report
market
muscular atrophy
Antibody Drug Conjugate Global Market Report 2023: Featuring Seattle Genetics, F. Hoffman-La Roche, ImmunoGen, Bayer & More
Published:
2023-01-06
(Crawled : 17:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
22.58%
|
O:
0.04%
H:
0.0%
C:
-1.84%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-14.72%
|
O:
0.13%
H:
1.33%
C:
0.91%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
2.51%
|
O:
0.35%
H:
1.43%
C:
1.28%
drug
global
report
antibody
market
Blueprint Medicines Appoints John Tsai, M.D. to its Board of Directors
Published:
2023-01-06
(Crawled : 14:20)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
22.58%
|
O:
0.04%
H:
0.0%
C:
-1.84%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
2.51%
|
O:
0.35%
H:
1.43%
C:
1.28%
GE
|
News
|
$148.06
-3.19%
0.0%
9.5M
|
Electronic Technology
|
118.36%
|
O:
1.01%
H:
0.44%
C:
-0.1%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-32.84%
|
O:
0.6%
H:
1.44%
C:
0.9%
BPMC
|
$86.87
-2.28%
-2.34%
800K
|
Health Technology
|
87.01%
|
O:
-1.28%
H:
2.66%
C:
0.99%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-0.72%
|
O:
1.19%
H:
2.51%
C:
1.91%
Insights on the Allergic Conjunctivitis Global Market to 2031 - by Drug Class, Disease Type, Distribution Channel and Region
Published:
2023-01-05
(Crawled : 20:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
22.58%
|
O:
0.04%
H:
0.0%
C:
-1.84%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
2.51%
|
O:
0.35%
H:
1.43%
C:
1.28%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-18.93%
|
O:
0.74%
H:
0.44%
C:
0.07%
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
22.07%
|
O:
0.84%
H:
4.71%
C:
3.46%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
1.02%
|
O:
0.83%
H:
1.98%
C:
1.04%
drug
global
disease
distribution
market
← Previous
1
2
…
23
24
25
26
27
28
29
30
31
…
51
52
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.